Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Citi
QuintilesIMS
Julphar
Deloitte
Healthtrust
Medtronic
Accenture
Moodys

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089903

« Back to Dashboard

NDA 089903 describes PROCHLORPERAZINE EDISYLATE, which is a drug marketed by Morton Grove, Athenex Inc, Emcure Pharms Ltd, Hospira, Marsam Pharms Llc, Smith And Nephew, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, and Alpharma Us Pharms, and is included in fifteen NDAs. It is available from four suppliers. Additional details are available on the PROCHLORPERAZINE EDISYLATE profile page.

The generic ingredient in PROCHLORPERAZINE EDISYLATE is prochlorperazine edisylate. There are twenty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prochlorperazine edisylate profile page.
Summary for 089903
Tradename:PROCHLORPERAZINE EDISYLATE
Applicant:West-ward Pharms Int
Ingredient:prochlorperazine edisylate
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details
Pharmacology for NDA: 089903
Ingredient-typePhenothiazines
Suppliers and Packaging for NDA: 089903
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089903 ANDA Baxter Healthcare Corporation 0641-0491 E 0641-0491-25
PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089903 ANDA West-Ward Pharmaceuticals Corp. 0641-6135 N 0641-6135-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 5MG BASE/ML
Approval Date:Aug 29, 1989TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Chubb
Express Scripts
Fuji
McKinsey
UBS
Daiichi Sankyo
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.